Soluble selectins and the systemic inflammatory response syndrome after successful cardiopulmonary resuscitation

OBJECTIVEElevated cytokine levels have been reported after ischemia/reperfusion injury and might cause a systemic inflammatory response syndrome (SIRS) after successful cardiopulmonary resuscitation (CPR). It is unknown whether patients with SIRS after CPR exhibit higher levels of soluble adhesion m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care medicine 2000-07, Vol.28 (7), p.2360-2365
Hauptverfasser: Geppert, Alexander, Zorn, Gerlinde, Karth, Georg Delle, Haumer, Markus, Gwechenberger, Marianne, Koller-Strametz, Jeanette, Heinz, Gottfried, Huber, Kurt, Siostrzonek, Peter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVEElevated cytokine levels have been reported after ischemia/reperfusion injury and might cause a systemic inflammatory response syndrome (SIRS) after successful cardiopulmonary resuscitation (CPR). It is unknown whether patients with SIRS after CPR exhibit higher levels of soluble adhesion molecules than patients without SIRS and whether SIRS or elevation of adhesion molecules is associated with outcome after CPR. We analyzed the relationships among various CPR-related variables, plasma levels of E- and P-selectin, the occurrence of SIRS after CPR, and the development of sepsis and outcome. DESIGNProspective, controlled study. SETTINGIntensive care unit at a university hospital. PATIENTSA total of 25 patients on the second day after successful CPR and 7 non-critically ill control patients. INTERVENTIONSBlood sampling for determination of plasma levels of soluble (s) E- and P-selectin. MEASUREMENTS AND MAIN RESULTSSIRS was a frequent finding after CPR (66% of all patients) unrelated to time until return of spontaneous circulation (SIRS, 17 ± 13 mins; no SIRS, 19 ± 16 mins;p = .761), epinephrine dose (SIRS, 4 ± 5 mg; no SIRS, 5 ± 6 mg;p = .906), or serum lactate level after CPR (SIRS, 8.6 ± 2.6 mmol/L; no SIRS, 8.7 ± 4.0 mmol/L;p = .174). sP-selectin levels were higher in patients with SIRS (291.7 ± 227.4 ng/mL) compared with patients without SIRS (113.4 ± 88.4 ng/mL;p = .018) or with non-critically ill patients (116.9 ± 33.4 ng/mL;p = .031). Compared with non-critically ill control patients (42.8 ± 19.4 ng/mL), sE-selectin levels were higher in patients with (96.2 ± 47.3 ng/mL;p = .023) and without SIRS (99.5 ± 65.7 ng/mL;p = .030). sP-selectin was higher in patients developing sepsis within 1 wk after CPR (n = 9) than in patients without sepsis (350.2 ± 233.4 ng/mL vs. 158.5 ± 157.8 ng/mL;p = .022) and sE-selectin levels were higher in nonsurvivors (n = 5) than in survivors (144.2 ± 62.4 ng/mL vs. 85.7 ± 45.3 ng/mL;p = .025) whereas SIRS was unrelated to the development of sepsis (p = .4) and unrelated to survival (p = .4). CONCLUSIONSSIRS is an unspecific finding after CPR with only minor impact on outcome. Determination of sP- and sE-selectin early after CPR might help to identify patients at a high risk for sepsis or for an adverse outcome, respectively.
ISSN:0090-3493
1530-0293
DOI:10.1097/00003246-200007000-00030